Document is current
Any future updates will be listed below
-
Authors
van den Eijnde, Sharon E. J. D. https://orcid.org/0009-0005-6839-9761
Koekenbier, Eva L.
van der Linden, Paul D.
Oosterheert, Jan Jelrik
Bonten, Marc J. M.
van Werkhoven, Cornelis H.
,
Ammerlaan, H.S.M.
Bouma, H.R.
Dofferhoff, A.S.M.
Gompelman, M.
Jong, E.
Kampschreur, L.M.
Prins, J.M.
- License Information
-
More Information
Article History
Received: 19 September 2025
Accepted: 8 April 2026
First Online: 23 April 2026
Declarations
:
: Not applicable.
: Not applicable.
: SE, EK, PL, JJO, MB and CW report financial support was provided by Netherlands Organisation for Health Research and Development. PL reports a relationship with AMR care network Noord Holland Flevoland that includes funding grants. PL reports a relationship with Dutch Working Party of Antimicrobial policies that includes board membership. MB reports a relationship with MSD Merck Sharp & Dohme AG that includes consulting or advisory and funding grants. MB reports a relationship with Sanofi that includes board membership and funding grants. MB reports a relationship with GSK that includes consulting or advisory and funding grants. MB reports a relationship with Atea Pharmaceuticals that includes funding grants. MB reports a relationship with Shionogi that includes consulting or advisory. CW reports a relationship with DaVolterra that includes funding grants. CW reports a relationship with bioMérieux SA that includes funding grants. CW reports a relationship with LimmaTech that includes funding grants. CW reports a relationship with MSD Merck Sharp & Dohme AG that includes consulting or advisory and funding grants. CW reports a relationship with Sanofi-Pasteur that includes consulting or advisory.
